Xbiome
PrivateLast Round
Series B
Extension
Dec 22, 2021
Total Funding Raised
$141.5M
Company Overview
Xbiome is a biotechnology company that develops an AI-driven drug discovery platform and microbial pharmaceuticals for treating intestinal disorders and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xbiome Comparables
Compare Xbiome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evogene | 77% | |
| Enterome | 76% | |
| MaaT Pharma | 76% |
Xbiome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Dec 22, 2021 | ||||
| Series B Extension | Dec 1, 2020 | ||||
| Series B | Nov 4, 2019 | ||||
| Series A Extension | Jan 3, 2019 | ||||
| Series A | Aug 3, 2018 |
Key People
Founding team and executive leadership
Xbiome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tsinghua Shenzhen International Graduate School | Series A Extension |
| ZhenFund | Series A |
| Tiantu Capital | Series B Extension |
| HIKE Capital | Series B Extension |
| Legend Capital | Series B Extension, Series B |
| 5Y Capital | Series B, Series B Extension, Series A |
| Primavera Venture Partners | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 11, 2025
Monthly visitors grew 249% MoM, from 35 to 122.
- Nov 4, 2019
$14M round led by Legend Capital.
Xbiome Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Xbiome's valuation, stock price, and market status.
Is Xbiome a public or private company?
Xbiome is a private company.
What is the current stock price of Xbiome?
Xbiome is a private company with no public stock price. No recent secondary market data is available.
How much is Xbiome worth (valuation)?
Valuation information for Xbiome is not publicly available.
Can I buy Xbiome stock?
Xbiome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Xbiome's last funding round?
Xbiome's most recent funding round was Series B Extension on December 22, 2021.
Who are the main investors in Xbiome?
Key investors in Xbiome include Tsinghua Shenzhen International Graduate School, Legend Capital, Primavera Venture Partners, Gaorong Capital.
Will Xbiome IPO soon?
No public IPO plans have been announced for Xbiome.
How can I track Xbiome secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Xbiome's secondary market activity and sign up for updates.